SCHEMBL804650

SCHEMBL804650

CC1CN(C)CC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12435793 1.00
SCHEMBL8231765 1.00
SCHEMBL12225944 1.00
SCHEMBL12587089 1.00
SCHEMBL12435843 1.00
SCHEMBL25134511 0.85
SCHEMBL14067483 0.85
SCHEMBL22631656 0.85
SCHEMBL24832715 0.85
SCHEMBL24315928 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049979-A2 NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME SENDA BIOSCIENCES, INC. (US) 2024-03-07 WO disclosed
US-20230348459-A1 PYRROLIDINE COMPOUND AND USE THEREOF SIMCERE PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 US disclosed
US-20230348459-A1 PYRROLIDINE COMPOUND AND USE THEREOF SIMCERE PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 US disclosed
US-RE49686-E1 Nitrogen-containing heterocyclic compound and use of same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-10 US disclosed
US-RE49686-E1 Nitrogen-containing heterocyclic compound and use of same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-10 US disclosed
EP-3604308-B1 SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY BOEHRINGER INGELHEIM INT (DE) 2023-09-13 EP disclosed
WO-2023116934-A1 KRASG12D PROTEIN HYDROLYSIS REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州泽璟生物制药股份有限公司 2023-06-29 WO disclosed
WO-2023083283-A1 DRUG COMBINATION FOR TREATING TUMOR, AND APPLICATION THEREOF 先声药业有限公司 2023-05-19 WO disclosed
EP-3507275-B1 CXCR3 RECEPTOR AGONISTS RECEPTOS LLC (US) 2023-04-26 EP disclosed
US-20230046859-A1 Bicyclic Compounds and their Uses NOVARTIS PHARMA AG (CH) 2023-02-16 US disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
WO-2009072643-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-11 WO disclosed
US-20090110873-A1 Polymer Hybrid Membrane Structures CORNING INCORPORATED 2009-04-30 US disclosed
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2007144129-A2 PYRROLIDINE DERIVATIVES USEFUL AGAINST DISEASES THAT DEPENDS ON ACTIVITY OF RENIN NOVARTIS AG (CH) 2007-12-21 WO disclosed
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-5854164-A Method for preparing catalyst component for olefin polymerization, catalyst for olefin polymerization and process for producing olefin polymer with the catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-12-29 US disclosed
CN-1152582-A Method for preparing catalyst component for olefin polymerization, catalyst for olefin polymerization and process for producing olefin polymer with catalyst SUMITOMO CHEMICAL CO (JP) 1997-06-25 CN disclosed
EP-0768322-A1 Method for preparing catalyst component for olefin polymerization, catalyst for olefin polymerization and process for producing olefin polymer with the catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-04-16 EP disclosed